Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Zuckerman AL, Pourvaziri A, Ebb DH, Boyraz B. Case 26-2023: A 15-Year-Old Girl with Abdominal Pain and an Ovarian Mass. N Engl J Med. 2023;389(8):750-758.

Aguilar R, Khan L, Arslanovic N, Birmingham K, Kasliwal K, Posnikoff S, et al. Multivalent binding of the tardigrade Dsup protein to chromatin promotes yeast survival and longevity upon exposure to oxidative damage. Res Sq. 2023.

Hacken ET, Sewastianik T, Yin S, Hoffmann GB, Gruber M, Clement K, et al. In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities. Blood Cancer Discov. 2023;4(2):150-169.

Zhang T, Kutler D, Scognamiglio T, Gudas LJ, Tang X-. Transcriptomic analysis predicts the risk of progression of premalignant lesions in human tongue. Discov Oncol. 2023;14(1):24.

Metzler VM, de Brot S, Haigh DB, Woodcock CL, Lothion-Roy J, Harris AE, et al. The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer. Front Cell Dev Biol. 2023;11:1116424.

Santo EE, Ribel-Madsen R, Stroeken PJ, de Boer VC, Hansen NS, Commandeur M, et al. FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity. Aging Cell. 2023;22(3):e13763.

Sasset L, Chowdhury KH, Manzo OL, Rubinelli L, Konrad C, J Maschek A, et al. Sphingosine-1-phosphate controls endothelial sphingolipid homeostasis via ORMDL. EMBO Rep. 2023;24(1):e54689.

Schreidah CM, Fahmy LM, Lapolla BA, Kwinta BD, Magro CM, Geskin LJ. Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. Am J Dermatopathol. 2023;45(8):572-576.

Geyer JT, Kluk MJ. Current Landscape of Ancillary Diagnostic Testing in Chronic Lymphocytic Leukemia. Surg Pathol Clin. 2023;16(2):411-421.

Ruan J, Moskowitz A, Mehta-Shah N, Sokol L, Chen Z, Kotlov N, et al. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood. 2023;141(18):2194-2205.